RENAL TUBULAR DYSFUNCTION IN PATIENTS WITH MUCOCUTANEOUS LEISHMANIASIS TREATED WITH PENTAVALENT ANTIMONIALS-Reference-Cited by-同舟云学术

RENAL TUBULAR DYSFUNCTION IN PATIENTS WITH MUCOCUTANEOUS LEISHMANIASIS TREATED WITH PENTAVALENT ANTIMONIALS

Published:1983-09 Issue:8349 Volume:322 Page:569
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Veiga J.P.R.,Wolff E.R.,Sampaio R.N.,Marsden P.D.

Publisher

Elsevier BV

Subject

General Medicine

Reference10 articles.

1. Leishmamose tegumentar americana: Casuistica do Hospital Escola da UnB;Sampaio;An Bras Dermatol,1980

2. Solustibosan in the treatment of kala azar;Chung;Chinese Med J,1944

3. The treatment of kala azar with sodium antimony gluconate (Stibatin). further observations on the treatment of 32 cases;Chakravarty;Indian Med Gaz,1945

4. Renal clearance of pentavalent antimony (sodium stibogluconate);Rees;Lancet,1980

5. Report of the informal meeting on the chemotherapy of visceral leishmaniasis. Mimeographed document;World Health Organisation,1982

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drugs and nanoformulations for the management of Leishmania infection: a patent and literature review (2015-2022);Expert Opinion on Therapeutic Patents;2023-03-04

2. Trace elements, toxic metals, and metalloids in kidney disease;Nutritional Management of Renal Disease;2022

3. Trace Elements, Toxic Metals, and Metalloids in Kidney Disease;Nutritional Management of Renal Disease;2013

4. A review of the potential protective effects of pentoxifylline against drug-induced nephrotoxicity;European Journal of Clinical Pharmacology;2012-11-22

5. Liposomal amphotericin B in the treatment of visceral leishmaniasis in immunocompromised patients;Transplant Infectious Disease;2010-05-30